Stroke Prevention in Atrial Fibrillation II "SPAF II"

Completed

Phase N/A Results

Summary of Purpose

To define the benefits and risks associated with warfarin compared with aspirin in a large number of patients followed for a longer period of time (compared to SPAF I) according to age and inherent risk of thromboembolism.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Institute for Neurological Disorders and Stroke, NIH

Trial Design

Two parallel, randomized, placebo-controlled clinical trials of 1100 patients at 16 U.S. centers. One trial studied patients >75 years of age, the other <=75.

Contacts

Not available